Teladoc Health, Inc. (TDOC) Free Cash Flow CAGR:21.66%(TTM)
Free cash flow CAGR uses precomputed cash-flow statement history.
Over longer horizons, Teladoc Health, Inc.'s Free Cash Flow CAGR averages 4.62% over 3 years and 29.46% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Free cash flow CAGR measures how Teladoc Health, Inc.'s cash generation has grown. FCF represents the cash available for dividends, buybacks, debt reduction, or reinvestment.
TDOC Free Cash Flow CAGR Chart
Teladoc Health, Inc. (TDOC)
TDOC Quarterly Free Cash Flow Growth (YoY)
Free Cash Flow growth vs the same quarter one year earlier, last 20 quarters.
TDOC Free Cash Flow CAGR History
| Year | Start FCF | End FCF | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $282.89M | $285.46M | +$2.57M | +0.91% | +0.91% |
| 2024 | $193.67M | $282.89M | +$89.22M | +46.07% | +46.07% |
| 2023 | $172.81M | $193.67M | +$20.86M | +12.07% | +12.07% |
| 2022 | $185.46M | $172.81M | $-12.64M | -6.82% | -6.82% |
| 2021 | $-79.55M | $185.46M | +$265.01M | N/A | N/A |
| 2020 | $18.97M | $-79.55M | $-98.52M | -519.38% | N/A |
| 2019 | $-13.27M | $18.97M | +$32.24M | N/A | N/A |
| 2018 | $-39.96M | $-13.27M | +$26.69M | N/A | N/A |
| 2017 | $-55.21M | $-39.96M | +$15.25M | N/A | N/A |
| 2016 | $-55.00M | $-55.21M | $-209.00K | N/A | N/A |
| 2015 | $-13.09M | $-55.00M | $-41.91M | N/A | N/A |
| 2014 | $-7.35M | $-13.09M | $-5.75M | N/A | N/A |
Quarterly Free Cash Flow: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $7.86M | -90.8% | — |
| Q4 2025 | $85.12M | +25.3% | +51.3% |
| Q3 2025 | $67.95M | -24.6% | -14.0% |
| Q2 2025 | $90.16M | — | +3.9% |
| Q1 2025 | -$15.67M | — | — |
| Q4 2024 | $56.26M | -28.8% | -56.3% |
| Q3 2024 | $79.03M | -8.9% | +16.3% |
| Q2 2024 | $86.77M | +1016.6% | -12.6% |
| Q1 2024 | $7.77M | -94.0% | -28.0% |
| Q4 2023 | $128.68M | +89.4% | +116.8% |
| Q3 2023 | $67.95M | -31.6% | +14.8% |
| Q2 2023 | $99.28M | +819.8% | +10.4% |
| Q1 2023 | $10.79M | -81.8% | — |
| Q4 2022 | $59.35M | +0.3% | -26.1% |
| Q3 2022 | $59.19M | -34.2% | -21.5% |
| Q2 2022 | $89.93M | — | +80.1% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Charles Divita